Moderna reports surprise profit on higher-than-expected COVID …

Moderna Reports Surprise Profit On Higher-than-expected COVID …

2 weeks from now

Nov 7, 2024  · Moderna still expects to make less from COVID vaccine sales this year than it did in 2023, however, and reaffirmed its 2024 sales forecast of $3 billion to $3.5 billion. The …

reuters.com

Moderna Reports Third Quarter 2024 Financial Results And …

2 weeks from now

Nov 7, 2024  · RSV vaccine sales were $10 million in the quarter. Cost of Sales: Cost of sales for the third quarter of 2024 was $514 million, which included third-party royalties of $92 million, …

modernatx.com

Moderna Posts Unexpected Q3 Profit, Driven By Cost Cuts And

2 weeks from now

Nov 7, 2024  · Moderna’s new RSV vaccine added $10 million in U.S. sales. The company reiterated its 2024 outlook. Moderna plans further expense reductions, targeting $1 billion in savings by 2027.

msn.com

Moderna's Stock Pops After Biotech Ekes Out A Surprise Profit, And ...

2 weeks from now

Nov 7, 2024  · Net product sales rose 4% to $1.8 billion in the quarter, driven by demand for the updated COVID-19 vaccine. Sales of Spikevax came to $1.8 billion, while FactSet was …

morningstar.com

Moderna's Stock Pops After Surprise Quarterly Profit, Even As …

2 weeks from now

Feb 22, 2024  · Sales of Moderna's Spikevax COVID vaccine came to $2.8 billion in the fourth quarter and totaled $6.7 billion for fiscal 2023, whereas the company had previously said it …

morningstar.com

Moderna Stock Jumps After Company Posts Surprise Quarterly …

2 weeks from now

Shares of Moderna closed roughly 13% higher Thursday after the company posted a surprise quarterly profit, boosted by deferred revenue and cost cuts, even as it saw slumping sales …

msn.com

Moderna Surges 14% After Covid Vaccine-Maker Surprises With …

2 weeks from now

Feb 22, 2024  · During the fourth quarter, sales declined 45% year over year, "primarily due to a reduction in sales of the company's Covid-19 vaccine," Moderna said in its news release. …

investors.com

Moderna Rakes In Surprise Profits Ahead Of 400% Vaccine Price Hike

2 weeks from now

May 5, 2023  · While financial analysts expected the company to post revenue of $1.18 billion and a loss of $1.77 per share in the first quarter, the company reported $1.86 billion in revenue …

arstechnica.com

Moderna Reports Surprise Profit, Sets Out Road Map For RSV …

2 weeks from now

Feb 22, 2024  · Waning demand for COVID vaccines and anticipation of a loss for 2023 led to a steep decline in Moderna's shares last year. Moderna posted a profit of $217 million, or 55 …

yahoo.com

Pfizer Shows Profit Growth From Cost Cuts And Steadier COVID Sales

2 weeks from now

3 days ago  · Its cost of sales fell 22% in the quarter to $5.9 billion from $7.6 billion a year ago. Revenue from COVID vaccine Comirnaty brought in sales of $3.38 billion, while antiviral …

reuters.com